NEW YORK, July 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022

http://www.reportlinker.com/p0923283/Nuclear-Medicine-Imaging-Devices-Global-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

Report Details

Our latest pharma report -Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022- offers a comprehensive view of the global nuclear medicine imaging systems market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses, revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the nuclear medicine imaging systems market in 2011 to be worth $1.5bn. Growth in this market will be driven by new technology and varied uses of the technology.

Despite experiencing a decline in sales volume and reduced demand in the aftermath of the global economic recession, the nuclear medicine market recovered well, and has seen strong growth in recent years. Much of this growth has been linked to the advent of hybrid units, such as positron emission tomography/computed tomography (PET/CT) scans, where both anatomical and functional images can be captured. For example, the combination of Positron Emission Tomography (PET) with other imaging modalities, such as MRI (Magnetic Resonance Imaging) has allowed for the imaging of cartilage damage, previously thought unreliable.

Nuclear Medicine Imaging Devices: Market Global Market Prospects 2012-2022report forecasts the size and value of leading national/regional markets including the US, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this diagnostic technology over the forecast period. Developed nuclear medicine markets such as the US and UK are highly saturated and the focus is likely to be towards upgrading stand-alone PET and SPECT system with fully integrated hybrid units, that offer a high level of anatomical and functional detail. Emerging countries such asChinaandIndiawill offer more opportunity, due a lack of nuclear medicine facilities and technologies, and increased healthcare spending. It has been predicted that healthcare investment in these countries is expected to double in the next seven years.

How will the nuclear medicine imaging systems market develop this decade? Which regions offer the most significant growth opportunities between 2012 and 2022? Which of the nuclear medicine based imaging devices are growing most strongly? Who are the leading companies in the nuclear medicine imaging systems market? What are some promising technological developments in the market?

Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Why you should buyNuclear Medicine Imaging Devices: Global Market Prospects 2012-2022

Go here to read the rest:

Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022